Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Calderon Gerardo Familiar See Remarks | CC Chemours Company | Buy | 1,935 | $15.53 | $30.1K Buy | Form 4 ↗ |
| Aug 11, 2026 | Denise Dignam Chief Executive Officer, Director | CC Chemours Company | Buy | 3,378 | $14.95 | $50.5K Buy | Form 4 ↗ |
| Aug 7, 2026 | Alister Cowan Director | CC Chemours Company | Buy | 13,000 | $15.62 | $203.1K Buy | Form 4 ↗ |
| Aug 7, 2026 | Michael Robert Foley See Remarks | CC Chemours Company | Buy | 1,934 | $15.51 | $30.0K Buy | Form 4 ↗ |
| Aug 7, 2026 | Joseph T. Martinko See Remarks | CC Chemours Company | Buy | 1,940 | $15.47 | $30.0K Buy | Form 4 ↗ |
| Aug 7, 2026 | Mary B. Cranston Director | CC Chemours Company | Buy | 6,000 | $15.83 | $95.0K Buy | Form 4 ↗ |
| Aug 6, 2026 | Shane Hostetter Chief Financial Officer | CC Chemours Company | Buy | 3,350 | $14.94 | $50.0K Buy | Form 4 ↗ |
| Aug 8, 2025 | Denise Dignam President & CEO, Director | CC Chemours Company | Buy | 4,068 | $12.06 | $49.1K Buy | Form 4 ↗ |
| Jun 3, 2025 | Damian Gumpel See Remarks | CC Chemours Company | Buy | 7,822 | $9.95 | $77.8K Buy | Form 4 ↗ |
| Jun 2, 2025 | Damian Gumpel See Remarks | CC Chemours Company | Buy | 13,400 | $9.22 | $123.5K Buy | Form 4 ↗ |
| May 19, 2025 | Shane Hostetter Chief Financial Officer | CC Chemours Company | Buy | 4,450 | $11.28 | $50.2K Buy | Form 4 ↗ |
| Nov 7, 2024 | Alvenia Scarborough SVP Corp Communications & CBO | CC Chemours Company | Sale | 7,500 | $20.64 | $154.8K Sale | Form 4 ↗ |
12 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:14 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances